Trial Profile
A study comparing the effect of Panitumumab and cetuximab given in combination with irinotecan in KRAS wild-type metastatic colorectal cancer patients who were treated with fluoropyrimidine, oxaliplatin, and irinotecan previously
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jul 2016
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Panitumumab (Primary) ; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 01 Jul 2016 Results published in the Anticancer Research
- 19 Dec 2015 New trial record